PURPOSE OF REVIEW: Despite their increased cardiovascular risk and its continuous relationship with cholesterol, until recently only diabetic patients with marked dyslipidaemia were routinely offered lipid-lowering therapy. The secondary prevention statin trials led to more widespread cholesterol lowering in patients with coronary disease and diabetes. Here we review the results of recent randomized trials, which included substantial numbers of patients with diabetes and no vascular disease....Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Cardiovascular outcomes among participants with diabetes in the recent large statin trials.
If you are the owner of this record, you can report an update to it here: Report update to this record